| Stage | MELI | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.2B | 100.00% | $8.0B | 100.00% | MELI ×1.26 |
| Gross profit | $2.9B | 28.35% | $1.5B | 18.92% | MELI +9.4pp |
| Operating income | $683M | 6.72% | $714M | 8.88% | CVNA +2.2pp |
| Pre-tax income | $606M | 5.96% | $552M | 6.87% | CVNA +0.9pp |
| Net income | $466M | 4.58% | $483M | 6.01% | CVNA +1.4pp |
| Stage | MELI | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $10.2B100.00% | $8.0B100.00% | MELI ×1.26 |
| Gross profit | 28.35%$2.9B | 18.92%$1.5B | MELI +9.4pp |
| Operating income | 6.72%$683M | 8.88%$714M | CVNA +2.2pp |
| Pre-tax income | 5.96%$606M | 6.87%$552M | CVNA +0.9pp |
| Net income |
| 4.58%$466M |
| 6.01%$483M |
| CVNA +1.4pp |
No shared counterparties.